A potent inhibitor of PARP1 and PARP2 (IC50 = 5 and 1 nM, respectively) but is less effective against the PARP tankyrase-1 (IC50 = 1.5 μM); can be used in cells and in animals, alone or in combination therapy with alkylating agents, to block BER and increase cancer cell death